

share
Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) CAS NO 1179992-99-4
Unit Price:
CAS No.:1179992-99-4
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Moxifloxacin Related Compound F (25 mg) (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid) is a high-purity reference standard critical for analytical and quality control processes in the pharmaceutical industry. This compound serves as a specified impurity and degradation product of the broad-spectrum fluoroquinolone antibiotic, Moxifloxacin, enabling precise monitoring and control of drug substance and product quality. It is an essential material for research laboratories, analytical service providers, and pharmaceutical manufacturers engaged in method development, validation, and regulatory compliance for Moxifloxacin-based therapeutics.
Application
- Pharmaceutical Impurity Profiling and Control: Used as a certified reference standard for the identification and quantification of Related Compound F in Moxifloxacin Active Pharmaceutical Ingredient (API) and finished drug products.
- Analytical Method Development & Validation (HPLC/LC-MS): Essential for developing, optimizing, and validating chromatographic methods to separate and analyze Moxifloxacin and its related substances.
- Stability Studies and Forced Degradation Testing: Employed to identify and track the formation of this specific impurity under various stress conditions (e.g., heat, light, humidity, acid/base hydrolysis).
- Regulatory Compliance & Documentation: Supports the preparation of regulatory submissions (e.g., for FDA, EMA) by providing a characterized impurity standard for specification setting and quality assurance.
- Quality Control (QC) Laboratory Testing: Serves as a primary standard in routine QC release testing of Moxifloxacin batches to ensure compliance with pharmacopeial limits (e.g., USP, EP).
- Research on Degradation Pathways: Aids in studying the chemical degradation mechanisms of Moxifloxacin to improve formulation stability and shelf-life.
- Calibration of Analytical Instruments: Used to calibrate and ensure the accuracy of UV detectors, mass spectrometers, and other analytical equipment in pharmaceutical analysis.
Basic Information
| Item | Details |
|---|---|
| Product Name | Moxifloxacin Related Compound F (25 mg) |
| CAS No. | 1179992-99-4 |
| Molecular Formula | C24H28FN3O4 |
| Molecular Weight | 441.50 g/mol |
| Synonyms | 1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; Moxifloxacin Impurity F; Moxifloxacin Related Substance F; Avelox Related Compound F; 7-[(4aS,7aS)-1-Methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid; BAY 12-8039 Impurity F; Moxifloxacin EP Impurity F |
| EINECS | Contact for details |
Quality Control
Our Moxifloxacin Related Compound F is manufactured under controlled conditions and undergoes rigorous analytical testing to ensure the highest standards of identity, purity, and consistency. Each batch is supplied with a comprehensive Certificate of Analysis (COA) detailing results from advanced techniques such as HPLC, NMR, and MS. Our quality system is designed to support pharmaceutical research and regulatory compliance, with specifications aligned to the requirements of major pharmacopeias. Certificates of Analysis are available upon request.
Storage
Preserve in a tightly closed container, protected from light. Store at controlled room temperature, 15-25°C (59-77°F). This product is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccant use.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white solid |
| Identification (HPLC) | Retention time corresponds to reference standard |
| Identification (IR) | Spectrum conforms to reference spectrum |
| Assay (HPLC) | ≥ 95.0% |
| Purity (HPLC, Area %) | ≥ 98.0% |
| Related Substances (HPLC) | Individual unknown impurity: ≤ 0.5% Total impurities: ≤ 2.0% |
| Residual Solvents (GC) | Complies with ICH Q3C guidelines |
| Water Content (KF) | ≤ 5.0% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pregabalin Ep Impurity A CAS NO 181289-23-6


Sulfamethazine-N4-Acetyl CAS NO 100-90-3


Pseudomorphine (Morphine Impurity) CAS NO 125-24-6


Dextrorphan D-Tartrate CAS NO 125-73-5


8-Acetyl Ludaconitine CAS NO 127-29-7


Oxythiamine Hydrochloride CAS NO 136-16-3


Dl-Normetanephrine Hydrochloride CAS NO 1011-74-1


Hydrochlorothiazide Impurity G CAS NO 1025-75-8


Prednisone Impurity 24 CAS NO 1058-04-4


Cinepazide Impurity 5 CAS NO 1078-64-4


n-Nitrosodiethanolamine CAS NO 1116-54-7


10-Hydroxynortriptyline CAS NO 1156-99-6


Nicorandil Impurity 16 CAS NO 1157-74-0


16-Dehydro Pregnenolone Acetate Impurity 3 CAS NO 1173-11-1


17Beta-Hydroxy-4-Androsten-3-One 17-D-Glucuronide CAS NO 1180-25-2


6,6',12'-Trimethoxy-2-Methyloxyacanthan-7-Ol CAS NO 1183-76-2


Thiamine Impurity 27 CAS NO 1196-75-4


4-Hydroxytriamterene CAS NO 1226-52-4


Betamethasone Impurity 7 CAS NO 1249-19-0


Benzocaine Impurity D CAS NO 1333-08-0
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






